- Home
- ARWR vs CVCO Comparison
ARWR vs CVCO Comparison
Compare ARWR & CVCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- CVCO
- Stock Information
- Founded
- ARWR 2003
- CVCO 1965
- Country
- ARWR United States
- CVCO United States
- Employees
- ARWR N/A
- CVCO N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- CVCO Homebuilding
- Sector
- ARWR Health Care
- CVCO Consumer Discretionary
- Exchange
- ARWR Nasdaq
- CVCO Nasdaq
- Market Cap
- ARWR 5.1B
- CVCO 4.3B
- IPO Year
- ARWR 1993
- CVCO N/A
- Fundamental
- Price
- ARWR $39.24
- CVCO $553.62
- Analyst Decision
- ARWR Strong Buy
- CVCO Buy
- Analyst Count
- ARWR 8
- CVCO 2
- Target Price
- ARWR $47.75
- CVCO $522.50
- AVG Volume (30 Days)
- ARWR 1.8M
- CVCO 165.6K
- Earning Date
- ARWR 11-25-2025
- CVCO 10-30-2025
- Dividend Yield
- ARWR N/A
- CVCO N/A
- EPS Growth
- ARWR N/A
- CVCO 34.06
- EPS
- ARWR N/A
- CVCO 23.02
- Revenue
- ARWR $572,976,000.00
- CVCO $2,094,716,000.00
- Revenue This Year
- ARWR $21,287.22
- CVCO $10.79
- Revenue Next Year
- ARWR N/A
- CVCO $5.69
- P/E Ratio
- ARWR N/A
- CVCO $24.20
- Revenue Growth
- ARWR 2816.20
- CVCO 16.60
- 52 Week Low
- ARWR $9.57
- CVCO $393.53
- 52 Week High
- ARWR $40.48
- CVCO $602.57
- Technical
- Relative Strength Index (RSI)
- ARWR 65.60
- CVCO 51.11
- Support Level
- ARWR $36.73
- CVCO $559.21
- Resistance Level
- ARWR $40.48
- CVCO $602.57
- Average True Range (ATR)
- ARWR 1.70
- CVCO 19.44
- MACD
- ARWR -0.20
- CVCO 0.97
- Stochastic Oscillator
- ARWR 78.79
- CVCO 57.84
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About CVCO Cavco Industries Inc. When Issued
Cavco Industries Inc designs and produces factory-built homes under the Cavco Homes, Fleetwood Homes, and Palm Harbor Homes brands. It also produces modular homes, park model homes, and vacation cabins, as well as commercial structures, among others. The company operates principally in two segments: Factory-built housing, which includes wholesale and retail systems-built housing operations, and the Financial services segment, which includes manufactured housing consumer finance and insurance. Cavco receives a majority of its revenue from the Factory-built housing segment.